Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Smartcella Solutions AB has 1 pending office action in the Medical Devices & Mechanical Engineering technology area. The portfolio's active matters are confined to 1 distinct examiner and a distinct art unit, reflecting a narrow administrative footprint. This singular focus allows for a streamlined approach to managing the current patent application. The concentration in a single art unit suggests that the technology being patented is specialized within the broader mechanical engineering field. By focusing on the requirements of a single group, the applicant can better anticipate the specific technical hurdles common to that area.
PATEL, SHEFALI DILIP serves as the busiest examiner, with 1 pending office action under review. This specific examiner is responsible for the only active office action in the portfolio. For the applicant, this means that the outcome of the current prosecution efforts depends entirely on the interactions with this one official. Understanding the specific requirements of the Medical Devices & Mechanical Engineering art unit will be essential for addressing the pending matter effectively. Because PATEL, SHEFALI DILIP is the only examiner involved, the applicant can develop a consistent communication strategy. The presence of 1 pending office action with the busiest examiner ensures that no other matters are currently competing for attention.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PATEL, SHEFALI DILIP | 1 | 58.0% | +27.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17852177 | METHODS OF DELIVERING CELLS AND THERAPEUTIC AGENTS TO ORGANS AND EXTRAVASCULAR SITES | PATEL, SHEFALI DILIP | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17852177 | METHODS OF DELIVERING CELLS AND THERAPEUTIC AGENTS TO ORGANS AND EXTRAVASCULAR SITES | PATEL, SHEFALI DILIP | — |
| Art Unit | Apps |
|---|---|
| 3783 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17852177 | METHODS OF DELIVERING CELLS AND THERAPEUTIC AGENTS TO ORGANS AND EXTRAVASCULAR SITES | PATEL, SHEFALI DILIP | 3783 | §103§112 | Final Rejection | — | Pending | Jun 28, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial